233 related articles for article (PubMed ID: 22253197)
1. Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress.
Cheng KW; Agarwal R; Mitra S; Lee JS; Carey M; Gray JW; Mills GB
EMBO Mol Med; 2012 Feb; 4(2):125-41. PubMed ID: 22253197
[TBL] [Abstract][Full Text] [Related]
2. Rab25 in cancer: a brief update.
Mitra S; Cheng KW; Mills GB
Biochem Soc Trans; 2012 Dec; 40(6):1404-8. PubMed ID: 23176489
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells.
Liu Y; Tao X; Jia L; Cheng KW; Lu Y; Yu Y; Feng Y
Mol Med Rep; 2012 Nov; 6(5):1006-12. PubMed ID: 22940905
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional analysis of FIP2 binding to the endosome-localised Rab25 GTPase.
Lall P; Horgan CP; Oda S; Franklin E; Sultana A; Hanscom SR; McCaffrey MW; Khan AR
Biochim Biophys Acta; 2013 Dec; 1834(12):2679-90. PubMed ID: 24056041
[TBL] [Abstract][Full Text] [Related]
5. Rab25 and RCP in cancer progression.
Cho KH; Lee HY
Arch Pharm Res; 2019 Feb; 42(2):101-112. PubMed ID: 30761451
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
7. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB
Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842
[TBL] [Abstract][Full Text] [Related]
8. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
Mitra S; Federico L; Zhao W; Dennison J; Sarkar TR; Zhang F; Takiar V; Cheng KW; Mani S; Lee JS; Mills GB
Oncotarget; 2016 Jun; 7(26):40252-40265. PubMed ID: 27259233
[TBL] [Abstract][Full Text] [Related]
9. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY
Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698
[TBL] [Abstract][Full Text] [Related]
10. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y; Xin XY; Chen BL; Ma X
Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
[TBL] [Abstract][Full Text] [Related]
12. Rab25 suppresses colon cancer cell invasion through upregulating claudin‑7 expression.
Cho SJ; Jeong BY; Yoon SH; Park CG; Lee HY
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131227
[TBL] [Abstract][Full Text] [Related]
13. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
14. Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC.
Wang J; Zhou P; Wang X; Yu Y; Zhu G; Zheng L; Xu Z; Li F; You Q; Yang Q; Zhuo W; Sun J; Chen Z
Cell Prolif; 2019 May; 52(3):e12592. PubMed ID: 30848009
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J
Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059
[TBL] [Abstract][Full Text] [Related]
16. A novel radiotracer to image glycogen metabolism in tumors by positron emission tomography.
Witney TH; Carroll L; Alam IS; Chandrashekran A; Nguyen QD; Sala R; Harris R; DeBerardinis RJ; Agarwal R; Aboagye EO
Cancer Res; 2014 Mar; 74(5):1319-28. PubMed ID: 24590807
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the role Rab25 in energy metabolism and cancer using extracellular flux analysis and material balance.
Mitra S; Molina J; Mills GB; Dennison JB
Methods Mol Biol; 2015; 1298():195-205. PubMed ID: 25800844
[TBL] [Abstract][Full Text] [Related]
18. Rab25 is responsible for phosphoinositide 3-kinase/AKT‑mediated cisplatin resistance in human epithelial ovarian cancer cells.
Fan Y; Wang L; Han X; Liu X; Ma H
Mol Med Rep; 2015 Mar; 11(3):2173-8. PubMed ID: 25405658
[TBL] [Abstract][Full Text] [Related]
19. Rab25 influences functional Cav1.2 channel surface expression in arterial smooth muscle cells.
Bannister JP; Bulley S; Leo MD; Kidd MW; Jaggar JH
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C885-93. PubMed ID: 27076616
[TBL] [Abstract][Full Text] [Related]
20. Expression of Ras-related protein 25 predicts chemotherapy resistance and prognosis in advanced non-small cell lung cancer.
Ma YF; Yang B; Li J; Zhang T; Guo JT; Chen L; Li M; Chu J; Liang CY; Liu Y
Genet Mol Res; 2015 Oct; 14(4):13998-4008. PubMed ID: 26535714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
